What is Neuronetics's cash & equivalents?

Neuronetics (STIM) reported cash & equivalents of $13.21M in Q1 2026.

How has Neuronetics's cash & equivalents changed year-over-year?

Neuronetics's cash & equivalents decreased by 34.7% year-over-year, from $20.22M to $13.21M.

What is the long-term trend for Neuronetics's cash & equivalents?

Over 5 years (2020 to 2025), Neuronetics's cash & equivalents has grown at a -10.5% compound annual growth rate (CAGR), from $48.96M to $28.13M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Neuronetics STIM Cash & Equivalents

Cash & Equivalents at other companies

LifeStance Health GroupLFST

$194.8M+45.0%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$320.68M—

StereotaxisSTXS

$14.62M+36.7%

Neuropace, Inc.NPCE

$15.63M-42.4%

Neurocrine BiosciencesNBIX

$274.5M+35.8%

ClearPoint NeuroCLPT

$36.52M+195%

Other financials

Income statement

See full

Revenue$34.5M+7.8%

Gross profit$16.2M+2.6%

Operating income-$9.0M+18.3%

Net income-$10.8M+14.9%

EPS (diluted)-$0.16+23.8%

Balance sheet

See full

Total debt$85.4M+3.5%

Total equity$13.3M-62.6%

Total assets$125.4M-11.7%

Cash flow

See full

Operating cash flow-$9.4M+44.6%

CapEx$197.0K-10.0%

Free cash flow-$9.6M+44.1%

Valuation

See full

Market cap$90.46M-59.6%

Enterprise value$162.64M-44.6%

P/S0.6×-1.4×

Profitability

See full

Gross margin48%-15.6pp

Operating margin-19.4%-6.9pp

Net margin-24.5%-8.7pp

FCF margin-9.4%-4.1pp

Returns & leverage

See full

Return on equity-152.4%-1.4pp

Debt / equity6.4×+4.1×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuronetics's cash & equivalents?: Neuronetics (STIM) reported cash & equivalents of $13.21M in Q1 2026.
How has Neuronetics's cash & equivalents changed year-over-year?: Neuronetics's cash & equivalents decreased by 34.7% year-over-year, from $20.22M to $13.21M.
What is the long-term trend for Neuronetics's cash & equivalents?: Over 5 years (2020 to 2025), Neuronetics's cash & equivalents has grown at a -10.5% compound annual growth rate (CAGR), from $48.96M to $28.13M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.